title: Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.
authors.forename: R
authors.initials: R
authors.lastname: Klaasen
authors.forename: C A
authors.initials: CA
authors.lastname: Wijbrandts
authors.forename: A W
authors.initials: AW
authors.lastname: van Kuijk
authors.forename: D
authors.initials: D
authors.lastname: Pots
authors.forename: D M
authors.initials: DM
authors.lastname: Gerlag
authors.forename: P P
authors.initials: PP
authors.lastname: Tak
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D013583:Synovial Membrane / Q000187:drug effects / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; C482345:SYVN1 protein, human; D044767:Ubiquitin-Protein Ligases